RE:RE:RE:fidelity? Would not be surprised if the Boston Investors are long gone. They bought at less than 0.20 and most likely Sold at 0.28. At least the smart ones.
They wanted to bring PMN through Stage 1 Clinical Trials. So far nothing and the competition is growing.
What we need is a New CEO to get this Company moving into the right direction and at FULL force!